#amtagvi
Latest news and interesting information about amtagvi.
Iovance Biotherapeutics: stock gains on melanoma data
Iovance Biotherapeutics stock gains momentum on real-world melanoma data for Amtagvi. Despite losses, analysts see upside from manufacturing efficiencies and label expansion.
...
